Full Text View
Tabular View
No Study Results Posted
Related Studies
Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus (MRSA) Osteomyelitis (VOTSMO)
This study is ongoing, but not recruiting participants.
Study NCT00324922   Information provided by University of Washington
First Received: May 9, 2006   Last Updated: July 27, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteomyelitis
Additional conditions recognized in this trial
Staphylococcal Infections
More general conditions related to this trial
Bacterial Infections
Bone Diseases
Bone Diseases, Infectious
Gram-Positive Bacterial Infections
Infection
Musculoskeletal Diseases
Interventions listed in this trial
trimethoprim-sulfamethoxazole
vancomycin
Additional drug interventions recognized in this trial
Sulfamethoxazole
Trimethoprim
Trimethoprim-Sulfamethoxazole Combination
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Folic Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
University of Washington


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services